Biblio Discovery — Demo Discovery Service

6 hasil untuk "Muhammad Al Azhar"

Menampilkan 1–6 · 0,20 detik · RSS

  1. Artikel Jurnal

    Enhancing Pediatric Cancer Survival in Indonesia: The Role of CAR T Cell Therapy

    Muhammad Al Azhar; Mururul Aisyi

    Indonesian Journal of Cancer, Vol. 18 No. 2 · 2024 · Inggris · DOAJ

    …and children diagnosed with refractory B-ALL [4]. A study by Maude et al. [5] reported high remission rates and durable responses in young adults and children with refractory or relapsed B-ALL treated with CAR T cells. Similarly, Park et al. [6] demonstrated long-term remissions and improved…

  2. Artikel Jurnal

    Profile of PD-L1 mRNA Expression in Childhood Acute Leukemia

    Muhammad Al Azhar; Chainurridha .; Mururul Aisyi

    Asian Pacific Journal of Cancer Biology, Vol. 6 No. 1 · 2021 · Inggris · DOAJ Scopus

    Background: Programmed Death Ligand 1 (PD-L1) expression was used to determine type of patients who respond to immunotherapy using immune checkpoint inhibitor in several solid malignancies. However, the role of PD-L1 in hematological malignancies is less explored. Therefore, we aim to investigate…

  3. Artikel Jurnal Teks lengkap

    Influence of Single Nucleotide Polymorphism of ENPP1 and ADIPOQ on Insulin Resistance and Obesity: A Case-Control Study in a Javanese Population

    Arianti, Rini; Ariani, Nia Lukita; Muhammad, Al Azhar dkk.

    Life (Basel) · 2021 · Inggris · PubMed Central

    Single nucleotide polymorphisms (SNPs) in obesity-related genes, such as ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) and adiponectin (ADIPOQ), potentially increase the risk of insulin resistance, the most common metabolic dysregulation related to obesity. We investigated the…

  4. Artikel Jurnal

    The mRNA Expression Profile of PD-1 and PD-L1 in Peripheral Blood of Colorectal Cancer Patients

    Ajoedi; Muhammad Al Azhar; Siti Nadliroh dkk.

    Indonesian Journal of Cancer, Vol. 13 No. 3 · 2019 · Inggris · DOAJ

    Background: Immunotherapy using immune checkpoint inhibitors has currently emerged as an effective treatment for a subset of colorectal cancer (CRC) patients. The roles of PD-1 and PD-L1 expression levels in peripheral blood to predict patient’s response to immune checkpoint inhibitors are not well…

  5. Artikel Jurnal

    PD-L1 copy number loss is associated with lower survival in women with advanced breast cancer in Indonesian cohort

    Ramadhan Karsono; Muhammad Al Azhar; Anggana Dyah Utari dkk.

    BMC Cancer, Vol. 26 No. 1 · 2026 · Inggris · DOAJ Scopus

    Abstract Background The prognostic value of PD-L1 copy number variation (CNV) in advanced breast cancer (BC) patients remains unclear. This study investigated the association between PD-L1 CNV and its prognostic significance in advanced BC. Methods PD-L1 CNV was analyzed using real-time PCR in…

  6. Artikel Jurnal

    Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparibResearch in context

    Xiaonan Zhang; Natallia Rameika; Lei Zhong dkk.

    EBioMedicine, Vol. 109 · 2024 · Inggris · DOAJ Scopus

    Summary: Background: Loss of heterozygosity (LOH) diminishes genetic diversity within cancer genomes. A tumour arising in an individual heterozygous for a functional and a loss-of-function (LoF) allele of a gene occasionally retain only the LoF allele. This can result in deficiency of specific…